The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹32.29Fair value₹159.02Bull₹267.79
FairClose
52-week traded range
52W low ₹115.3152W high ₹170.49
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading close to the consensus fair value
Gpt Healthcare Limited closed at ₹161.29, 1.4% above the consensus fair value of ₹159.02 drawn from 6 valuation models.
Financial DNA score 43/100 — Average. P/E of 31.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹136.36
-15.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
P/E Fair Value
₹267.79
+66.0%
EPS × 51.3x (sector P/E)
EPS=5.22, Sector P/E=51.3x
EV/EBITDA
₹96.68
-40.1%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=880M
Dividend Discount (DDM)
₹32.29
-80.0%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=2.53, r=10%, g=2%
Reverse DCF
₹161.29
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 13% | Historical: 0%
Margin of Safety
₹151.56
-6.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=202.08, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.